Fixed Competitive Price Supplier Levamisole Hydrochloride 16595-80-5 - Chromium picolinate 14639-25-9 – Starsky
Fixed Competitive Price Supplier Levamisole Hydrochloride 16595-80-5 - Chromium picolinate 14639-25-9 – Starsky Detail:
Description
Product Name: Chromium picolinate
CAS: 14639-25-9
MF: C18H12CrN3O6
MW: 418.3
EINECS: 1592732-453-0
storage temp: room temp
Merck: 14,2236
Specification
| Product Name | Chromium picolinate |
| Appearance | Red crystalline powder |
| Purity | 99% |
| MW | 418.3 |
Application
Used as medicines and health products, food additives
Chromium picolinate (CrPic) is a supplement or alternative medicine for type 2 diabetes. Experimental evidence shows that CrPic can uptake glucose by activating P38MAPK. Chromium is believed to enhance the action of insulin, thereby increasing the sensitivity of insulin to patients with type 2 diabetes.
Chromium picolinate (CrPic) is a supplement or alternative medicine for type 2 diabetes; experimental evidence shows that CrPic has an effect on the uptake of glucose through p38MAPK activation; chromium is believed to enhance insulin function and cause type 2 diabetes Increased insulin sensitivity
Storage
Stored in a dry and ventilated warehouse.
Product detail pictures:
Related Product Guide:
We usually keep on with the principle "Quality To start with, Prestige Supreme". We've been fully committed to offering our purchasers with competitively priced excellent solutions, prompt delivery and skilled support for Fixed Competitive Price Supplier Levamisole Hydrochloride 16595-80-5 - Chromium picolinate 14639-25-9 – Starsky, The product will supply to all over the world, such as: Belgium, Accra, Germany, Excellent quality, competitive price, punctual delivery and dependable service can be guaranteed. For further inquires please do not hesitate to contact us. Thank you - Your support continuously inspires us.
By Renata from Panama - 2017.09.29 11:19
The product manager is a very hot and professional person, we have a pleasant conversation, and finally we reached a consensus agreement.
By Alice from Belgium - 2017.10.13 10:47
